[1]
Fisher K,Vuppalanchi R,Saxena R, Drug-Induced Liver Injury. Archives of pathology & laboratory medicine. 2015 Jul
[PubMed PMID: 26125428]
[2]
Chalasani N,Bonkovsky HL,Fontana R,Lee W,Stolz A,Talwalkar J,Reddy KR,Watkins PB,Navarro V,Barnhart H,Gu J,Serrano J,United States Drug Induced Liver Injury Network., Features and Outcomes of 899 Patients With Drug-Induced Liver Injury: The DILIN Prospective Study. Gastroenterology. 2015 Jun
[PubMed PMID: 25754159]
[4]
Kuna L,Bozic I,Kizivat T,Bojanic K,Mrso M,Kralj E,Smolic R,Wu GY,Smolic M, Models of Drug Induced Liver Injury (DILI) - Current Issues and Future Perspectives. Current drug metabolism. 2018
[PubMed PMID: 29788883]
Level 3 (low-level) evidence
[5]
Chalasani NP,Hayashi PH,Bonkovsky HL,Navarro VJ,Lee WM,Fontana RJ, ACG Clinical Guideline: the diagnosis and management of idiosyncratic drug-induced liver injury. The American journal of gastroenterology. 2014 Jul;
[PubMed PMID: 24935270]
[6]
Navarro VJ,Khan I,Björnsson E,Seeff LB,Serrano J,Hoofnagle JH, Liver injury from herbal and dietary supplements. Hepatology (Baltimore, Md.). 2017 Jan
[PubMed PMID: 27677775]
[7]
Tujios SR,Lee WM, Acute liver failure induced by idiosyncratic reaction to drugs: Challenges in diagnosis and therapy. Liver international : official journal of the International Association for the Study of the Liver. 2018 Jan
[PubMed PMID: 28771932]
[8]
Njoku DB, Drug-induced hepatotoxicity: metabolic, genetic and immunological basis. International journal of molecular sciences. 2014 Apr 22;
[PubMed PMID: 24758937]
[9]
Real M,Barnhill MS,Higley C,Rosenberg J,Lewis JH, Drug-Induced Liver Injury: Highlights of the Recent Literature. Drug safety. 2019 Mar;
[PubMed PMID: 30343418]
[12]
Teschke R, Idiosyncratic DILI: Analysis of 46,266 Cases Assessed for Causality by RUCAM and Published From 2014 to Early 2019. Frontiers in pharmacology. 2019
[PubMed PMID: 31396080]
Level 3 (low-level) evidence
[13]
Fontana RJ, Pathogenesis of idiosyncratic drug-induced liver injury and clinical perspectives. Gastroenterology. 2014 Apr;
[PubMed PMID: 24389305]
Level 3 (low-level) evidence
[14]
Robles-Díaz M,Medina-Caliz I,Stephens C,Andrade RJ,Lucena MI, Biomarkers in DILI: One More Step Forward. Frontiers in pharmacology. 2016
[PubMed PMID: 27597831]
[15]
Teschke R,Danan G, Molecular Research on Drug Induced Liver Injury. International journal of molecular sciences. 2018 Jan 11
[PubMed PMID: 29324638]
[16]
Au JS,Navarro VJ,Rossi S, Review article: Drug-induced liver injury--its pathophysiology and evolving diagnostic tools. Alimentary pharmacology
[PubMed PMID: 21539586]
[17]
Kleiner DE,Chalasani NP,Lee WM,Fontana RJ,Bonkovsky HL,Watkins PB,Hayashi PH,Davern TJ,Navarro V,Reddy R,Talwalkar JA,Stolz A,Gu J,Barnhart H,Hoofnagle JH, Hepatic histological findings in suspected drug-induced liver injury: systematic evaluation and clinical associations. Hepatology (Baltimore, Md.). 2014 Feb;
[PubMed PMID: 24037963]
Level 1 (high-level) evidence
[18]
Shehu AI,Ma X,Venkataramanan R, Mechanisms of Drug-Induced Hepatotoxicity. Clinics in liver disease. 2017 Feb
[PubMed PMID: 27842774]
[19]
Ahmad J,Reddy KR,Tillmann HL,Hayashi PH,Chalasani N,Fontana RJ,Navarro VJ,Stolz A,Barnhart H,Cloherty GA,Hoofnagle JH, Importance of Hepatitis C Virus RNA Testing in Patients with Suspected Drug-Induced Liver Injury. Digestive diseases and sciences. 2019 Sep
[PubMed PMID: 30927209]
[20]
Ahmad J,Rossi S,Rodgers SK,Ghabril M,Fontana RJ,Stolz A,Hayashi PH,Barnhart H,Kleiner DE,Bjornsson ES, Sclerosing Cholangitis-Like Changes on Magnetic Resonance Cholangiography in Patients With Drug Induced Liver Injury. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association. 2019 Mar
[PubMed PMID: 29966706]
[21]
Howell LS,Ireland L,Park BK,Goldring CE, MiR-122 and other microRNAs as potential circulating biomarkers of drug-induced liver injury. Expert review of molecular diagnostics. 2018 Jan;
[PubMed PMID: 29235390]
[22]
Barnhill MS,Real M,Lewis JH, Latest advances in diagnosing and predicting DILI: what was new in 2017? Expert review of gastroenterology & hepatology. 2018 Oct
[PubMed PMID: 30111182]
Level 3 (low-level) evidence
[23]
Fontana RJ,Watkins PB,Bonkovsky HL,Chalasani N,Davern T,Serrano J,Rochon J, Drug-Induced Liver Injury Network (DILIN) prospective study: rationale, design and conduct. Drug safety. 2009;
[PubMed PMID: 19132805]